Zoetis (ZTS) Income towards Parent Company (2012 - 2026)

Zoetis' (ZTS) quarterly Income towards Parent Company came in at $601.0 million in Q1 2026, little changed year-on-year from $602.0 million in Q1 2025, and little changed on a QoQ basis from $603.0 million in Q4 2025.

Zoetis (ZTS) Income towards Parent Company (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Income towards Parent Company data on file, last reported at $601.0 million in Q1 2026.

  • On a quarterly basis, Income towards Parent Company changed 0.17% year-over-year to $601.0 million in Q1 2026; TTM through Mar 2026 was $2.6 billion, a 5.76% increase from a year earlier, with the FY2025 full-year figure at $2.7 billion, up 7.09% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at $601.0 million, roughly flat from $603.0 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for ZTS reached as high as $721.0 million in Q3 2025 and fell as low as $460.0 million in Q4 2022.
  • Historically, Income towards Parent Company has averaged $599.5 million across 5 years, with a median of $599.0 million in 2024.
  • On a YoY basis, Income towards Parent Company climbed as much as 26.65% in 2023 and fell as far as 7.24% in 2023.
  • Year by year, Income towards Parent Company stood at $460.0 million in 2022, then grew by 13.7% to $523.0 million in 2023, then gained by 11.09% to $581.0 million in 2024, then grew by 3.79% to $603.0 million in 2025, then retreated by 0.33% to $601.0 million in 2026.
  • Per Business Quant data, the three most recent Income towards Parent Company figures were $601.0 million in Q1 2026, $603.0 million in Q4 2025, and $721.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 601.00 Mn
Dec 31, 2025 603.00 Mn
Sep 30, 2025 721.00 Mn
Jun 30, 2025 718.00 Mn
Mar 31, 2025 602.00 Mn
Dec 31, 2024 581.00 Mn
Sep 30, 2024 692.00 Mn
Jun 30, 2024 624.00 Mn
Mar 31, 2024 599.00 Mn
Dec 31, 2023 523.00 Mn
Sep 30, 2023 596.00 Mn
Jun 30, 2023 670.00 Mn
Mar 31, 2023 551.00 Mn
Dec 31, 2022 460.00 Mn
Sep 30, 2022 528.00 Mn
Jun 30, 2022 529.00 Mn
Mar 31, 2022 594.00 Mn
Dec 31, 2021 413.00 Mn
Sep 30, 2021 552.00 Mn
Jun 30, 2021 511.00 Mn